Home
FDA Calendar
About & More
Testimonials
Useful Links
Our Disclaimer
Updates and Roadmap
Contribute
Create Company Profile
Create Drug Profile
Browse
Contact
FDA Calendar for Javelin Pharmaceuticals Inc. (JAV)
Login Now
|
Register (free)
Javelin Pharmaceuticals, Inc. (Javelin) is a specialty pharmaceutical company. It is engaged in the research, development and commercialization of products for the pain management market. The Company develops products optimized for relieving acute moderate-to-severe pain. In addition, the product choices available for the treatment of acute moderate-to-severe pain are limited in the doses that may be given due to side effects, including cardiovascular depression, tolerance and addiction, respiratory depression, constipation, sedation, and general diminution of quality of life. Javelin’s product candidates Dyloject (injectable diclofenac), Ereska (intranasal ketamine) and Rylomine (intranasal morphine) are focused on treating a variety of pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain, such as orthopedic injury pain, procedural pain and burn pain.
Around The Net
Latest News
Twitter Stream
Yahoo Message Board
Google Message Board
You are reading news provided by a variety of web sources.
Drug Pipeline
Drug Name
Type Of Drug
FDA Status
Drug Phase
Dyloject
Pain Management
Pending Decision
Phase 3
Events
No future events listed at this time, please check back later.
1 past event(s) found.
Click here
to view them.
Outcome
Past Events
Javelin Pharmaceuticals Inc.
10/03/2010
Past Event
FDA Decision:
FDA decision.
(relates to the drug
Dyloject
)
Add New Event
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Event
Important Links
No links found.
Add New Link
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Link
$0.00
0
1/1/0001 12:00:00 AM
Sponsors
Other Links
Corporate Website
Analyst Estimates (MarketWatch)
CNN Money
Google Finance
Guru Focus
Major Holders
MSN Money
SEC Filings (EDGAR Online)
Seeking Alpha
Yahoo! Finance